Back to
AQR CAPITAL MANAGEMENT LLC
KNSA
Showing 0 of 11 quarters
Position history for
AQR CAPITAL MANAGEMENT LLC's holdings in KINIKSA PHARMACEUTICALS-A
As of its Q1 2024 13F, AQR Capital Management held 159,323 shares of KNSA (Kiniksa Pharmaceuticals), worth $3.1M. AQR Capital Management's 13F filings listed KNSA from Q4 2022 to Q1 2024, 6 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.